|
|
A case of gastric adenocarcinoma of the fundic gland type and literature review#br# |
KOU Mengjia1 GONG Yucheng1 WANG Zhibin2 |
1.The Second Clinical Medical School, Beijing University of Chinese Medicine, Beijing 100078, China;
2.Department of Gastroenterology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing 100078, China |
|
|
Abstract Gastric adenocarcinoma of the fundic gland type (GA-FG) is a rare tumor that belongs to the new gastric cancer subtype. However, its pathogenesis is not clear, the submucosal infiltration rate is high, but the degree of malignancy is low, lymphatic and venous metastases are less common, and the prognosis is good. In previous reports, GA-FG was mostly submucosal bulge, and the tumor surface was whitish or faded. One case of GA-FG patient reported in this article was admitted to the Department of Spleen, Stomach and Hepatobiliary, Dongfang Hospital, Beijing University of Chinese Medicine on July 30, 2020. The shape of the lesion is a rare flat type, the surface of the tumor is reddish, and there are fundus gland polyps around the lesion. The clinical manifestations were acid reflux heartburn, history of proton pump inhibitor drugs, and endoscopic submucosal dissection treatment. There was no obvious abnormality after the operation. This article reports on the diagnosis and treatment process of patients, reviews and reviews relevant literature, and concludes that the endoscopic diagnosis of GA-FG has not yet formed a consensus and has limitations, and it is very easy to misdiagnose and miss diagnosis. However, it has unique clinicopathological characteristics, combined with morphology and immunophenotype, it can be diagnosed clearly. In terms of etiology, whether proton pump inhibitor is related to the occurrence of GA-FG requires more reports for research and demonstration.
|
|
|
|
|
[1] Takemoto T,Yokoi T,Maruta S,et al. Gastric adenocarcinoma with chief cell differentiation [J]. Pathol Int,2007, 57(8):517-522.
[2] Ueyama H,Yao T,Nakashima Y,et al. Gastric adenocarcinoma of fundic gland type (chief cell predominant type):proposal for a new entity of gastric adenocarcinoma [J]. Am J Surg Pathol,2010,34(5):609-619.
[3] Nagtegaal ID,Odze RD,Klimstra D,et al. The 2019 WHO classification of tumours of the digestive system [M]. Histopathology,2020,76(2):182-188.
[4] Benedict MA,Lauwers GY,Jain D. Gastric Adenocarcinoma of the Fundic Gland Type:Update and Literature Review [J]. Am J Clin Pathol,2018,149(6):461-473.
[5] 刘明,谢佳宜,陈振煜,等.胃底腺型胃癌的临床病理特征分析[J].现代消化及介入诊疗,2020,25(7):851-855.
[6] 张静,刘鑫,张贺军,等.胃底腺癌11例临床病理分析[J].中国微创外科杂志,2020,20(4):296-299.
[7] Nagini S. Carcinoma of the stomach:A review of epidemiology,pathogenesis,molecular genetics and chemoprevention [J]. World J Gastrointest Oncol,2012,4(7):156-169.
[8] 韩泽龙,陈振煜,罗晓蓓,等.国内首例胃底腺型胃癌病例报道[J].现代消化及介入诊疗,2018,23(3):427-429.
[9] Singhi AD,Lazenby AJ,Montgomery EA. Gastric Adenocarcinoma With Chief Cell Differentiation [J]. American Journal of Surgical Pathology,2012,36(7):1030-1035.
[10] Li CF,Wu X,Yang S,et al. Gastric adenocarcinoma of the fundic gland type:clinicopathological features of eight patients treated with endoscopic submucosal dissection [J]. Diagn Pathol,2020,15(1):131.
[11] Matsubara A,Sekine S,Kushima R,et al. Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum [J]. J Pathol,2013,229(4):579-587.
[12] Lee SH,Jeong EG,Soung YH,et al. Absence of GNAS and EGFL6 mutations in common human cancers [J]. Pathology,2008,40(1):95-97.
[13] Haastrup PF,Thompson W,S?覬ndergaard J,et al. Side Effects of Long-Term Proton Pump Inhibitor Use:A Review [J]. Basic Clin Pharmacol Toxicol,2018,123(2):114-121.
[14] Brusselaers N,Wahlin K,Engstrand L,et al. Maintenance therapy with proton pump inhibitors and risk of gastric cancer:a nationwide population-based cohort study in Sweden [J]. BMJ Open,2017,7(10):e017739.
[15] 王耀辉,韩梅,王洁,等.胃底腺型胃癌2例临床病理观察[J].临床与实验病理学杂志,2019,35(6):644-648.
[16] Miyazawa M,Matsuda M,Yano M,et al. Gastric adenocarcinoma of fundic gland type:Five cases treated with endoscopic resection [J]. World J Gastroenterol,2015,21(26):8208-8214.
[17] Chiba T,Kato K,Masuda T,et al. Clinicopathological features of gastric adenocarcinoma of the fundic gland (chief cell predominant type) by retrospective and prospective analyses of endoscopic findings [J]. Dig Endosc,2016,28(7):722-730.
[18] Ishibashi F,Fukushima K,Ito T,et al. Influence of Helicobacter pylori Infection on Endoscopic Findings of Gastric Adenocarcinoma of the Fundic Gland Type [J]. J Gastric Cancer,2019,19(2):225-233.
[19] Yao K,Anagnostopoulos GK,Ragunath K. Magnifying endoscopy for diagnosing and delineating early gastric cancer [J]. Endoscopy,2009,41(5):462-467.
[20] Matsumoto K,Ueyama H,Yao T,et al. Diagnostic limitations of magnifying endoscopy with narrow-band imaging in early gastric cancer [J]. Endosc Int Open,2020,8(10):E1233-E1242.
[21] Tohda G,Osawa T,Asada Y,et al. Gastric adenocarcinoma of fundic gland type:Endoscopic and clinicopathological features [J]. World J Gastrointest Endosc,2016,8(4):244-251.
[22] Okumura Y,Takamatsu M,Ohashi M,et al. Gastric Adenocarcinoma of Fundic Gland Type with Aggressive Transformation and Lymph Node Metastasis:a Case Report [J]. J Gastric Cancer,2018,18(4):409-416.
[23] Kato M,Uraoka T,Isobe Y,et al. A case of gastric adenocarcinoma of fundic gland type resected by combination of laparoscopic and endoscopic approaches to neoplasia with non-exposure technique (CLEAN-NET) [J]. Clin J Gastroenterol,2015,8(6):393-399.
[24] Li Y,Lu Yz,Yu C,et al. Efficacy analysis of endoscopic submucosal dissection in gastric adenocarcinoma of fundic gland type:five cases of more than 36 months of follow-up [J]. Translational Cancer Research,2019,8(5):1734-1740. |
|
|
|